Investor Relations – Merchavia

Overview

Company Profile

Presentation

Company Presentation

Reports

Immediate Reports

Financial

Financial Reports

Management

Management

Stock

Stock Chart

FAQ

FAQ

Alert

Mail Alert

Contact

Contact IR

Stock Quote

Tel Aviv: MRHL

38.50

Price

0.26%

Change percentage

0.1

Change

39.90

38.00

Last Update:24/05/2020

at:15:49

Presentations

Financial Reports

Immediate Reports

Cardiacsense (6.16%), has signed an exclusive distribution deal to sell medical watches

21/05/2020

Cardiacsense (6.34%), signed two exclusive distribution agreements for the sale of medical watches

12/05/2020

IFA (9.09%), has received the right to grant permission from the Innovation Authority for the R&D project for a mobile blood test device

06/05/2020

Cardiacsense (6.34%) – Positive Clinical Trial Clinical Trial Detection for Cardiac Disorders

04/05/2020

Read more

Investors News

Merhavia will invest an additional NIS 200,000 in EFA from eHealth incubator to develop a blood test system with immediate result

24/06/2019

Cardiacsense signs memorandum of understanding with leading European medical center for investment at $ 30 million

28/05/2019

Merhavia announces that RMDY has signed an agreement to use its digital medical system with US insurance giant Fortune500

06/05/2019

Senior PepsiCo executives and Boston Medical Scientific giant Boston Scientific join the Cardiacsens board

05/05/2019

Read more

Mail Alert

Subscribe to Receive Notifications by Email:

Stock Price

Tel Aviv: MRHL

38.50

Price

0.26%

Change percentage

0.1

Change

39.90

38.00

Last Update:24/05/2020

at:15:49